IPP Bureau
Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
By IPP Bureau - November 21, 2022
Omicron BA.5 continues to be the most prevalent sublineage in the United States (nearly 30% of cases) at the time of publication of the data
Ayurveda tech startup NirogStreet raises US $12 mn led by Jungle Ventures
By IPP Bureau - November 21, 2022
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
USFDA completes pre-approval inspection of BHL's Vadodara facility
By IPP Bureau - November 21, 2022
The pre-approval inspection of USFDA was completed successfully with ZERO 483 observation of the manufacturing facilities of Bajaj Healthcare Limited
Aurobindo Pharma receives 10 observations for Unit IX
By IPP Bureau - November 21, 2022
The company had responded to the agency and carried out the required corrective actions.
Eugia Pharma receives USFDA approval for Amphotericin B Liposome for Injection
By IPP Bureau - November 19, 2022
The product is expected to be launched by Q4 FY23.
Strides receives USFDA approval for Potassium Chloride Oral Solution
By IPP Bureau - November 19, 2022
The approval further strengthens the Potassium Chloride franchise for the company.
Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr
By IPP Bureau - November 19, 2022
The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022
Strand Life Sciences launches ‘Strand Genomic Wellness’
By IPP Bureau - November 18, 2022
Strand’s new offering will help people better understand and manage diseases through genomic sequencing
Apollo launches national program to promote rational use of antibiotics
By IPP Bureau - November 18, 2022
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Zydus Lifesciences gets exclusive marketing rights for CanAssist Breast
By IPP Bureau - November 18, 2022
Zydus becomes the only Indian oncology player to venture into prognosis and diagnosis along with treatment planning
CPhI & P-MEC India expo to encourage cost-effective solutions in India’s march towards a Rs 10.5 lakh crore pharma market by 2030
By IPP Bureau - November 17, 2022
The show will be a part of the India Pharma Week, a marquee celebration catering to every need of the pharma community attendees
Experts highlight the rising cases of diabetes in youngsters
By IPP Bureau - November 16, 2022
India is home to nearly 80 million diabetics and this number is expected to rise to a staggering 134 million in the next 25 years.
Cadila recognized for its contribution to leprosy treatment
By IPP Bureau - November 16, 2022
Cadila Pharmaceuticals was felicitated during the plenary session of the 21st International Leprosy Congress
Intuitive installs 100 robotic-assisted surgical system
By IPP Bureau - November 16, 2022
Prime Minister Narendra Modi attended an event marking the 100th robotic-assisted surgical system installation at U. N. Mehta Institute of Cardiology, Ahmedabad.
SMS Pharma revenue down 9%
By IPP Bureau - November 15, 2022
Within the API segment, ~20% of the revenues came from the domestic market and ~80% from the exports market
